Vitamin D and Metabolic Syndrome

Metabolic syndrome — the cluster of central obesity, insulin resistance, dyslipidaemia, and hypertension — is associated with lower serum 25(OH)D in observational studies. Whether correcting deficiency improves metabolic syndrome is a partial "yes" with important caveats.

The consistent observational signal

Cross-sectional studies (NHANES, EPIC-Norfolk, others) consistently find inverse correlation between 25(OH)D and metabolic syndrome prevalence. Adults in the highest 25(OH)D quintile have 30–40% lower metabolic syndrome prevalence. Individual metabolic syndrome components — waist circumference, insulin resistance (HOMA-IR), triglycerides, HDL — all show similar patterns.

Causation vs confounding

Metabolic syndrome is causally associated with vitamin D deficiency largely because obesity dilutes serum 25(OH)D (see our obesity page). Vitamin D deficiency is a marker of metabolic syndrome as much as a contributor. Mendelian randomisation studies support obesity → low vitamin D more strongly than the reverse.

Supplementation trials

Practical guide

  1. Test 25(OH)D in patients with metabolic syndrome — deficiency is common (obesity dilutes serum levels).
  2. Correct deficiency with adjusted dose (obese adults need 2-3x standard): 3,000–5,000 IU/day for BMI 30–35, higher above BMI 35.
  3. Vitamin D is an adjunct — the metabolic-syndrome interventions that work are weight loss, physical activity, dietary change, and (where indicated) metformin, GLP-1 agonists, or antihypertensives.
  4. Do not use vitamin D as a substitute for the evidence-based interventions.
Sponsored
Not medical advice. Metabolic syndrome components need independent management — high BP, high glucose, high triglycerides, abdominal obesity — vitamin D adjunct does not replace addressing each.

Related tools & guides

Advertisement